Invex Therapeutics (ASX:IVX)
Invex has received an approval from the UK’s MHRA to commence its IIH EVOLVE Phase III clinical trial in the country. The trial will study patients with Idiopathic Intracranial Hypertension (IIH), and they will be randomly treated with Presendin versus placebo once weekly over 24 weeks.
Invex Therapeutics (ASX:IVX)Invex has received an approval from...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.91M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $8.357K | 2.779M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 6945059 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 4900300 | 9 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| IVX (ASX) Chart |